The third edition of the Surviving the Dutch program has started!
On March 7th, the third edition of the Surviving the Dutch program started. A group of international community members will work together weekly to master the Dutch language, learn more about the Dutch culture and get to know each other better through social activities.
Leaders in Life Sciences – #11 Peter van Dijken
Peter van Dijken, Managing Director Gezond Leven bij TNO.
Pivot Park Screening Center has Assay Development Fund available for early drug discovery project
The Assay Development Fund supports scientists in the Netherlands that are working with or aiming to work with a charity for an early drug discovery project, by providing expertise in assay development.
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency.
Press release: Reaching big heights at Pivot Park
The new Grizzly building has reached it’s highest point at Pivot Park this week. Grizzly provides space for offices and laboratories. This space is much needed, because successful start-ups and scale-ups are outgrowing their space. With the arrival of Grizzly, Pivot Park stimulates innovation and employment. Companies will have the space and facilities to develop further. This allows them to excel further and to continue to play a leading role worldwide in the field in which they operate.
New Oncolines publication in Cancers
In a recent paper published in Cancers, Yvonne Grobben from Oncolines investigated the role of various immunosuppressive amino acid-metabolizing enzymes in high-grade serous ovarian cancer.
Leaders in Life Sciences – #10 Pieter van der Meer
Pieter van der Meer, Managing Partner Gilde Healthcare
Get to know: Pedersen & Partners
Pedersen & Partners is a leading global Executive Search, Leadership Consulting and Board Services firm Pedersculturally diverse and committed to Diversity & Inclusion. With close to 400 colleagues around the world, it is operating 54 wholly owned offices in 50 countries across Europe, the Middle East, Africa, Asia & the Americas. Founded in 2001 by Poul Pedersen, Pedersen & Partners has applied the values Trust – Relationship – Professionalism to our interactions with clients and executives, as well as internally.
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities
Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), announces the acquisition of Oncolines, a Netherlands-based CRO that provides early biology services and cell-line profiling assays. Oncolines is Symeres’ third acquisition in the past ten months, and will take group revenues to over €100m.
10 years Pivot Park: Pivot Park
Pivot Park has become an essential location for biopharmaceutical innovation and drug discovery in Europe. The latest addition to Pivot Park is an eight-floor multitenant office and lab space, and the shell of the next building is already up. This additional accommodation is a testament to the steady, continuous growth of Pivot Park.
“It was a revelation for me. As Accountants, we usually look back at the end of every year. But to work with partners in Life Science we needed a change of mind set. We wanted to collaborate and facilitate more, to help our clients achieve their goals. We think along with our clients and help them build healthy, growing companies.”
or call
Pivot Park – Building RK
Kloosterstraat 9
5349 AB Oss
The Netherlands
+31 (0)412 – 84 60 10
info@pivotpark.com
Pivot Park Exploitatie B.V.
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.
We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.
